The effect of dermatology consultations in secondary care on treatment outcome and quality of life in new adult patients with atopic dermatitis

British Journal of Dermatology

Volumn 154, Issue 5, 2006, Pages 942-949

  Baron, S E ^a   Morris, P K ^b,c   Dye, L ^b   Fielding, D ^c   Goulden, V ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Atopic dermatitis; Dermatology consultations; Dermatology Life Quality Index; SCORAD; Treatment outcome

Indexed keywords

ADULT; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; ARTICLE; ATOPIC DERMATITIS; CONSULTATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DISEASE SEVERITY; ECZEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; PATIENT REFERRAL; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SEX DIFFERENCE; SEX RATIO; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STUDENT T TEST; TREATMENT OUTCOME;

ADOLESCENT; ADULT; DERMATITIS, ATOPIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; PATIENT DROPOUTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; REFERRAL AND CONSULTATION; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TREATMENT OUTCOME;

EID: 33645824767     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.07104.x     Document Type: Article

References (35)

1. Williams HC. Is the prevalence of atopic dermatitis increasing? Clin Exp Dermatol 1992 17 385 91.
2. Charman C Chambers C Williams H. Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring? J Invest Dermatol 2003 120 932 41.
3. Williams HC. Appendix 8. Prevalence of atopic eczema. In: Dermatology Health Care Needs Assessment Stevens A Raftery J, eds). Oxford Radcliffe Medical Press 1997 70.
4. Herd RM Tidman MJ Prescott RJ et al. Prevalence of atopic eczema in the community: the Lothian atopic dermatitis study. Br J Dermatol 1996 135 18 19.
5. Hoare C Li Wan Po A Williams H. Systemic review of treatments for atopic eczema. Health Technol Assess 2000 4 1 191.
6. Herd RM Tidman MJ Prescott RJ Hunter JAA. The cost of atopic eczema. Br J Dermatol 1996 135 20 3.
7. Finlay AY. Quality of life in atopic dermatitis. J Am Acad Dermatol 2001 45 Suppl. 1 S64 6.
8. Charman CR Morris AD Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 2000 142 931 6.
9. Ashcroft DM Dimmock P Garside R et al. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. BMJ 2005 330 516.
10. Green C Colquitt JL Kirby J et al. Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation. Health Technol Assess 2004 8 1 120.
11. Meurer M Folster-Holst R Wozel G et al. Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study. Dermatology 2002 205 271 7.
12. Granlund H Erkko P Remitz A et al. Comparison of cyclosporin and UVAB phototherapy for intermittent one-year treatment of atopic dermatitis. Acta Derm Venereol (Stockh) 2001 81 22 7.
13. Williams HC Burney PG Hay RJ et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994 131 383 96.
14. Williams HC Burney PG Strachan D Hay RJ. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. II. Observer variation of clinical diagnosis and signs of atopic dermatitis. Br J Dermatol 1994 131 397 405.
15. Williams HC Burney PG Pembroke AC Hay RJ. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. Br J Dermatol 1994 131 406 16.
16. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 1993 186 23 31.
17. Finlay AY Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994 19 210 16.
18. Lewis V Finlay AY. 10 years experience of the Dermatology Life Quality Index (DLQI). J Invest Dermatol Symp Proc 2004 9 169 80.
19. Finlay AY. Measurement of disease activity and outcome in atopic dermatitis. Br J Dermatol 1996 135 509 15.
20. Kunz B Oranje AP Labreze L et al. Clinical validation and guidelines for the SCORAD index: Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1997 195 10 19.
21. Zaghloul SS Goodfield MJ. Objective assessment of compliance with psoriasis treatment. Arch Dermatol 2004 140 408 14.
22. Zaghloul SS Goodfield MJ. Objective assessment of compliance with treatments in acne. Br J Dermatol 2005 152 1015 21.
23. Broberg A Kalimo K Lindblad B et al. Parental education in the treatment of childhood atopic eczema. Acta Derm Venereol (Stockh) 1990 70 495 9.
24. Paterson W Moffat L. Education about eczema. Dermatol Pract 1995 3 10 11.
25. Cork MJ Britton J Butler L et al. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol 2003 149 582 9.
26. Gradwell C Thomas KS English JS et al. A randomized controlled trial of nurse follow-up clinics: do they help patients and do they free up consultants' time? Br J Dermatol 2002 147 513 17.
27. Linnet J Jemec GBE. An assessment of anxiety and dermatology life quality in patients with atopic dermatitis. Br J Dermatol 1999 140 268 72.
28. Lundberg L Johannesson M Silverdahl M et al. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol (Stockh) 2000 80 430 4.
29. Shum KW Lawton S Williams HC et al. The British Association of Dermatologists audit of atopic eczema management in secondary care. Phase 3: audit of service outcome. Br J Dermatol 2000 142 721 7.
30. Finlay AY. Measures of the effect of adult severe atopic eczema on quality of life. J Eur Acad Dermatol Venereol 1996 7 149 54.
31. Khilji FA Gonzalez M Finlay AY. Clinical meanings of change of Dermatology Life Quality Index scores. Br J Dermatol 2002 147 Suppl. 62 50 (Abstract).
32. Ben-Gashir MA Seed PT Hay RJ. Quality of life and disease severity are correlated in children with atopic dermatitis. Br J Dermatol 2004 150 284 90.
33. Herd RM Tidman MJ Ruta DA et al. Measurement of quality of life in atopic dermatitis: correlation and validation of two different methods. Br J Dermatol 1996 136 502 7.
34. Charman CR Venn AJ Williams HC. Measurement of body surface involvement in atopic eczema: an impossible task? Br J Dermatol 1999 140 109 11.
35. Housman TS Patel MJ Camacho F et al. Use of the Self-Administered Eczema Area and Severity Index by parent caregivers: results of a validation study. Br J Dermatol 2002 147 1192 8.